BANK OF MONTREAL /CAN/ - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$1,000
-50.0%
1,5000.0%0.00%
Q4 2015$2,000
-33.3%
1,5000.0%0.00%
Q3 2015$3,0000.0%1,5000.0%0.00%
Q2 2015$3,000
+200.0%
1,500
+316.7%
0.00%
Q2 2014$1,0003600.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders